Multiple myeloma is a cancer of the plasma cells. It is considered terminal when it reaches the end stage, a point at which the disease can no longer be effectively treated. At this stage, the cancer has spread throughout the body, making it difficult to treat with chemotherapy or other treatments. Additionally, the bone marrow is significantly impaired, leading to a decrease in the production of healthy red blood cells, white blood cells, and platelets.
At this point, the patient may experience severe, debilitating symptoms, such as extreme fatigue, bone pain, anemia, and kidney failure. These symptoms, in addition to the spread of the cancer, make it difficult for the patient to perform everyday activities and lead a normal life.
At this stage, treatment is focused on controlling symptoms and improving quality of life, rather than attempting to cure the disease. Options may include radiation therapy, stem cell transplants, and immunotherapy. Additionally, doctors may recommend medications to reduce pain and improve overall health.
Ultimately, multiple myeloma is considered terminal when it has progressed to an advanced stage and can no longer be effectively treated. Treatment at this stage is focused on controlling symptoms and improving quality of life.